Profile
Camilo Colaco is the founder of ImmunoBiology Ltd., where he holds the title of Chief Scientific Officer starting in 1999.
He also worked as a Director at Quadrant Healthcare Plc and as a Lecturer at the University of Cambridge.
Dr. Colaco received an undergraduate degree from the University of London.
Camilo Colaco active positions
| Companies | Position | Start |
|---|---|---|
ImmunoBiology Ltd.
 ImmunoBiology Ltd. BiotechnologyHealth Technology ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom. | Founder | 1998-12-31 |
Former positions of Camilo Colaco
| Companies | Position | End |
|---|---|---|
| University of Cambridge | Corporate Officer/Principal | - |
Quadrant Healthcare Plc
 Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Director/Board Member | - |
Training of Camilo Colaco
| University of London | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Quadrant Healthcare Plc
Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Health Technology |
ImmunoBiology Ltd.
ImmunoBiology Ltd. BiotechnologyHealth Technology ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Camilo Colaco
